Letrozole in Patients With Hepatopulmonary Syndrome
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and possible benefit of
letrozole compared to placebo in patients with Hepatopulmonary Syndrome.